Structure–activity relationship of cytochrome bc1 reductase inhibitor broad spectrum antifungal ilicicolin H (cas 12689-26-8)

Add time:08/24/2019    Source:sciencedirect.com

Ilicicolin H is a broad spectrum antifungal agent showing sub micro g/mL MICs against Candida spp., Aspergillus fumigatus and Cryptococcus spp. It is a potent inhibitor (C50 2–3 ng/mL) of the mitochondrial cytochrome bc1 reductase with over 1000-fold selectivity against rat liver cytochrome bc1 reductase. Structure–activity relationship of semisynthetic derivatives by chemical modification of ilicicolin H and its 19-hydroxy derivative produced by biotransformation have been described. Basic 4′-esters and moderately polar N- and O-alkyl derivatives retained antifungal and the cytochrome bc1 reductase activities. 4′,19-Diacetate and 19-cyclopropyl acetate retained antifungal and enzyme activity and selectivity with over 20-fold improvement of plasma protein binding.

We also recommend Trading Suppliers and Manufacturers of ilicicolin H (cas 12689-26-8). Pls Click Website Link as below: cas 12689-26-8 suppliers

Prev:Biotransformation of antifungal ilicicolin H (cas 12689-26-8)
Next:Differential efficacy of inhibition of mitochondrial and bacterial cytochrome bc1 complexes by center N inhibitors antimycin, ilicicolin H (cas 12689-26-8) and funiculosin)